-+ 0.00%
-+ 0.00%
-+ 0.00%

Reviva Pharmaceuticals Plans RECOVER-2 Phase 3 Trial for Schizophrenia Drug Brilaroxazine

路透·12/23/2025 13:01:36

登錄查看新聞詳情